Michail S. Lionakis

23.2k total citations · 4 hit papers
218 papers, 9.9k citations indexed

About

Michail S. Lionakis is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Michail S. Lionakis has authored 218 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Infectious Diseases, 88 papers in Immunology and 85 papers in Epidemiology. Recurrent topics in Michail S. Lionakis's work include Antifungal resistance and susceptibility (100 papers), Fungal Infections and Studies (73 papers) and Immunodeficiency and Autoimmune Disorders (32 papers). Michail S. Lionakis is often cited by papers focused on Antifungal resistance and susceptibility (100 papers), Fungal Infections and Studies (73 papers) and Immunodeficiency and Autoimmune Disorders (32 papers). Michail S. Lionakis collaborates with scholars based in United States, United Kingdom and Germany. Michail S. Lionakis's co-authors include Dimitrios P. Kontoyiannis, Rebecca A. Drummond, Muthulekha Swamydas, Russell E. Lewis, Bart Jan Kullberg, Peter G. Pappas, Maiken Cavling Arendrup, Luis Ostrosky‐Zeichner, Georgios Chamilos and José Pedro Lopes and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Michail S. Lionakis

206 papers receiving 9.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Invasive candidiasis

2018 1.0k citations Michail S. Lionakis, Bart Jan Kullberg et al. profile →
Zygomycosis in a Tertiary‐Care Cancer Center in the Era of Aspergillus‐ Active Antifungal Therapy: A Case‐Control Observational Study of 27 Recent Cases

2005 489 citations Michail S. Lionakis et al. profile →
Pathogenesis and virulence of Candida albicans

2021 251 citations Michail S. Lionakis et al. profile →
Immune responses to human fungal pathogens and therapeutic prospects

2023 164 citations Michail S. Lionakis, Tobias M. Hohl et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michail S. Lionakis United States	52	5.5k	4.2k	2.5k	1.8k	835	218	9.9k
Tobias M. Hohl United States	52	3.3k 0.6×	2.5k 0.6×	3.3k 1.3×	2.0k 1.1×	959 1.1×	109	8.1k
Francesco Bistoni Italy	65	6.3k 1.2×	5.9k 1.4×	4.8k 1.9×	2.6k 1.5×	876 1.0×	305	14.2k
Georgios Chamilos United States	40	4.0k 0.7×	3.4k 0.8×	2.8k 1.1×	1.2k 0.7×	669 0.8×	77	7.8k
Brahm H. Segal United States	55	6.7k 1.2×	5.9k 1.4×	3.6k 1.5×	1.9k 1.1×	1.5k 1.8×	162	12.7k
Stuart M. Levitz United States	65	8.7k 1.6×	8.0k 1.9×	3.2k 1.3×	2.9k 1.6×	637 0.8×	178	14.4k
Frédéric Altare France	41	3.6k 0.7×	3.5k 0.8×	4.0k 1.6×	1.3k 0.7×	818 1.0×	85	8.0k
Thomas R. Hawn United States	47	3.0k 0.6×	3.5k 0.8×	5.3k 2.2×	2.0k 1.1×	305 0.4×	131	9.9k
Larry S. Schlesinger United States	59	4.3k 0.8×	3.6k 0.9×	3.6k 1.5×	3.0k 1.7×	456 0.5×	161	9.9k
Martin Schaller Germany	66	5.0k 0.9×	4.2k 1.0×	2.5k 1.0×	4.6k 2.6×	1.7k 2.1×	321	15.1k
Phillip D. Smith United States	52	2.0k 0.4×	1.9k 0.5×	4.0k 1.6×	1.8k 1.0×	531 0.6×	181	10.4k

Countries citing papers authored by Michail S. Lionakis

Since Specialization

Citations

This map shows the geographic impact of Michail S. Lionakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michail S. Lionakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michail S. Lionakis more than expected).

Fields of papers citing papers by Michail S. Lionakis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michail S. Lionakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michail S. Lionakis. The network helps show where Michail S. Lionakis may publish in the future.

Co-authorship network of co-authors of Michail S. Lionakis

This figure shows the co-authorship network connecting the top 25 collaborators of Michail S. Lionakis. A scholar is included among the top collaborators of Michail S. Lionakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michail S. Lionakis. Michail S. Lionakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lionakis, Michail S., et al.. (2025). Balancing IL-17–mediated protection and IFN-γ–driven pathology at mucocutaneous barriers. Trends in Immunology. 47(2). 96–105.

Mills, K., Vanessa Espinosa, Jigar V. Desai, et al.. (2025). GM-CSF–mediated epithelial-immune cell cross-talk orchestrates pulmonary immunity to Aspergillus fumigatus. Science Immunology. 10(105). eadr0547–eadr0547. 7 indexed citations

Philips, Rachael L., Colleen M. Lau, Tasha Morrison, et al.. (2025). An activating Stat1 mutant disrupts normal STAT4 innate lymphocyte programs during viral infection. Science Immunology. 10(107). eado5986–eado5986. 1 indexed citations

Hetemäki, Iivo, et al.. (2025). Thymoma-Associated Autoimmunity Is Th1 Driven and Can Be Ameliorated with Baricitinib. 1(CIS2025). 1 indexed citations

Epelbaum, Oleg, Alice Gallo de Moraes, Jody C. Olson, & Michail S. Lionakis. (2025). Invasive fungal infections in patients with liver disease: immunological and clinical considerations for the intensive care unit. Intensive Care Medicine. 51(2). 364–377. 2 indexed citations

Lahooti, Behnaz, Racheal G. Akwii, Fatema Tuz Zahra, et al.. (2023). Targeting endothelial permeability in the EPR effect. Journal of Controlled Release. 361. 212–235. 66 indexed citations

Ferré, Elise M. N., Vasileios Oikonomou, Chyi‐Chia Richard Lee, et al.. (2023). Case report: Discovery of a de novo FAM111B pathogenic variant in a patient with an APECED-like clinical phenotype. Frontiers in Immunology. 14. 1133387–1133387. 1 indexed citations

Ochoa, Sebastian, Michael S. Abers, Lindsey B. Rosen, et al.. (2023). Management and outcome of COVID-19 in CTLA-4 insufficiency. Blood Advances. 7(19). 5743–5751. 3 indexed citations

Rodrigues, Patrick Fernandes, Nicolas Bouladoux, Milena Mitrović, et al.. (2023). pDC-like cells are pre-DC2 and require KLF4 to control homeostatic CD4 T cells. Science Immunology. 8(80). eadd4132–eadd4132. 45 indexed citations

10.

Messina, Julia A., Charles Giamberardino, Jennifer L. Tenor, et al.. (2023). Susceptibility to Cryptococcus neoformans Infection with Bruton’s Tyrosine Kinase Inhibition. Infection and Immunity. 91(8). e0004223–e0004223. 6 indexed citations

11.

Laakso, Saila, Elina Holopainen, Corrado Betterle, et al.. (2021). Pregnancy Outcome in Women With APECED (APS-1): A Multicenter Study on 43 Females With 83 Pregnancies. The Journal of Clinical Endocrinology & Metabolism. 107(2). e528–e537. 11 indexed citations

12.

Lim, Ai Ing, Verena M. Link, Seong‐Ji Han, et al.. (2021). Prenatal maternal infection promotes tissue-specific immunity and inflammation in offspring. Science. 373(6558). 147 indexed citations

13.

Hurabielle, Charlotte, Verena M. Link, Nicolas Bouladoux, et al.. (2020). Immunity to commensal skin fungi promotes psoriasiform skin inflammation. Proceedings of the National Academy of Sciences. 117(28). 16465–16474. 70 indexed citations

14.

Burbelo, Peter D., Elise M. N. Ferré, JA Chiorini, et al.. (2019). Profiling Autoantibodies against Salivary Proteins in Sicca Conditions. Journal of Dental Research. 98(7). 772–778. 15 indexed citations

15.

Swidergall, Marc, Norma V. Solis, Zeping Wang, et al.. (2019). EphA2 Is a Neutrophil Receptor for Candida albicans that Stimulates Antifungal Activity during Oropharyngeal Infection. Cell Reports. 28(2). 423–433.e5. 48 indexed citations

16.

Collar, Amanda L., Muthulekha Swamydas, Morgan O’Hayre, et al.. (2018). The homozygous CX3CR1-M280 mutation impairs human monocyte survival. JCI Insight. 3(3). 22 indexed citations

17.

Zhang, Yuan, Chi A., Monica G. Lawrence, et al.. (2017). PD-L1 up-regulation restrains Th17 cell differentiation in STAT3 loss- and STAT1 gain-of-function patients. The Journal of Experimental Medicine. 214(9). 2523–2533. 57 indexed citations

18.

Sampaio, Elizabeth P., Li Ding, Stacey Rose, et al.. (2017). Novel signal transducer and activator of transcription 1 mutation disrupts small ubiquitin-related modifier conjugation causing gain of function. Journal of Allergy and Clinical Immunology. 141(5). 1844–1853.e2. 17 indexed citations

19.

Swamydas, Muthulekha, Ji‐Liang Gao, Timothy J. Break, et al.. (2016). CXCR1-mediated neutrophil degranulation and fungal killing promote Candida clearance and host survival. Science Translational Medicine. 8(322). 322ra10–322ra10. 64 indexed citations

20.

Doçi, Colleen L., Constantinos M. Mikelis, Michail S. Lionakis, Alfredo Molinolo, & J. Silvio Gutkind. (2015). Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma. Cancer Research. 75(14). 2937–2948. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact